Reduced Complexity of Quasispecies in HBV Surface and Polymerase Genes at Relapses after Antiviral Withdrawal
<p><strong>Figure S1.</strong> The clinical courses of patients included in this study. The longitudinal data of 5 ETV-<strong> (A)</strong> and 2 TDF- <strong>(B)</strong> treated CHB patients are plotted. Black horizontal bar to the top, time-periods when HBeAg was positive; black triangles, time-points when serum samples were obtained before NAs; grey triangles, time-points when serum samples were obtained at relapse after NA withdrawal; black arrows, time-points when patients started to receive NAs; grey arrows, time-points when NAs were withdrawn; black circles, HBV-DNA levels; grey squares, ALT levels.</p> <p> </p> <p><strong>Figure S2.</strong> The HBV genetic heterogeneity in the surface gene analyzed by deep-sequencing. <strong>(A)</strong> The distribution of well-defined functional domains within the surface gene. I, transmembrane domain I (TMD I: s8-22); cytosolic loop (CL: s22-80); II, transmembrane domain II (TMD II: s80-100); major hydrophilic region (MHR: s99-169); antigenic determinant (a determinant) region (located within MHR: s124-147); III, transmembrane domain III (TMD III: s170-192); IV, transmembrane domain IV (TMD IV: s202-224); hydrophobic C-terminus region (HCR: s170-226, includes TMD III-IV and the loop between them). The surface gene variants identified from ETV-treated patients are listed in <strong>(B)</strong> while those identified from TDF-treated patients are listed in <strong>(C)</strong>. Baseline, samples obtained from patients before antiviral treatments; Relapse, samples obtained from patients with virological reactivation after NA withdrawal.</p> <p> </p> <p><strong>Figure S3.</strong> The viral genetic variations in the reverse transcriptase domain of the polymerase gene analyzed by deep-sequencing. <strong>(A)</strong> The functional motifs in the reverse transcriptase domain. G, box G or box I; F, F box or box II: rt37-47; A, box A: rt75-90; B, box B: rt159-182; C, box C: rt201-210; D, box D: rt230-241; E, box E: rt247-257. The variants in the reverse transcriptase domain identified from ETV-treated patients are listed in <strong>(B)</strong> while those identified from TDF-treated patients are listed in <strong>(C)</strong>. Baseline, samples derived from patients before antiviral treatment; Relapse, samples derived from patients with virological relapses after NA withdrawal.</p>
ShareScore
28/100
Overall dataset sharing score
Score breakdown
These five areas show where the dataset supports — or may limit — practical reuse.
- Stewardship
- 8
- Harmonization
- 4
- Access
- 16
- Reuse readiness
- 0
- Engagement
- 0
Topics
Dataset details
- Repository
- zenodo
- Published
- June 21, 2020
- License
- cc-by-2.0
- DOI
- 10.5281/zenodo.3903603
Scored with release 0.9.0
ScienceDex for faculty
Your academic CV and NIH biosketch
Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.